An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates

Summary

This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection

Timeline

Start

2007-08

Primary completion

2007-10

Completion

2007-10

Publications

• Background Benjamin DK Jr, Smith PB, Arrieta A, Castro L, Sanchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, Hope WW, Walsh TJ. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther. 2010 Jan;87(1):93-9. doi: 10.1038/clpt.2009.200. Epub 2009 Nov 4.

Drugs

Indications